• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与裸金属支架相比,使用紫杉醇或雷帕霉素洗脱支架是否会进一步减少冠状动脉旁路移植术的需求?

Does the use of paclitaxel or rapamycin-eluting stent decrease further need for coronary-artery bypass grafting when compared with bare-metal stent?

作者信息

Lemos Hernani Pinto de, Atallah Alvaro Nagib

机构信息

Brazilian Cochrane Center, Universidade Federal de São Paulo-Escola Paulista de Medicina, São Paulo, Brazil.

出版信息

Sao Paulo Med J. 2007 Jul 5;125(4):242-5. doi: 10.1590/s1516-31802007000400010.

DOI:10.1590/s1516-31802007000400010
PMID:17992397
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11020538/
Abstract

CONTEXT AND OBJECTIVE

The safety and efficacy of drug-eluting stents reduce the need for surgical revascularization. The objective of the present study was to investigate whether paclitaxel or rapamycin-eluting stent are effective in avoiding the need for coronary-artery bypass grafting.

METHODS

This was a systematic review of the literature using the methodology of the Cochrane Collaboration. The type of study considered was controlled randomized trials; the type of intervention was drug-eluting or bare-metal stents; and the main outcome investigated was coronary-artery bypass grafting.

RESULTS

The ten studies included in this systematic review did not show any statistically significant difference between the drug-eluting stents and the bare-metal stents with regard to the outcome of coronary-artery bypass grafting (confidence interval: 0.31 to 1.42).

CONCLUSION

The surgical revascularization rate was not reduced by the use of drug-eluting stents.

摘要

背景与目的

药物洗脱支架的安全性和有效性降低了外科血管重建术的必要性。本研究的目的是调查紫杉醇或雷帕霉素洗脱支架在避免冠状动脉旁路移植术方面是否有效。

方法

这是一项采用Cochrane协作网方法对文献进行的系统评价。所考虑的研究类型为对照随机试验;干预类型为药物洗脱或裸金属支架;主要研究结果为冠状动脉旁路移植术。

结果

该系统评价纳入的十项研究显示,在冠状动脉旁路移植术的结果方面,药物洗脱支架与裸金属支架之间没有任何统计学上的显著差异(置信区间:0.31至1.42)。

结论

使用药物洗脱支架并未降低外科血管重建率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0476/11020538/57bcdaea3d69/1806-9460-spmj-125-04-242-gf01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0476/11020538/57bcdaea3d69/1806-9460-spmj-125-04-242-gf01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0476/11020538/57bcdaea3d69/1806-9460-spmj-125-04-242-gf01.jpg

相似文献

1
Does the use of paclitaxel or rapamycin-eluting stent decrease further need for coronary-artery bypass grafting when compared with bare-metal stent?与裸金属支架相比,使用紫杉醇或雷帕霉素洗脱支架是否会进一步减少冠状动脉旁路移植术的需求?
Sao Paulo Med J. 2007 Jul 5;125(4):242-5. doi: 10.1590/s1516-31802007000400010.
2
A systematic review and economic analysis of drug-eluting coronary stents available in Australia.澳大利亚可用药物洗脱冠状动脉支架的系统评价与经济分析。
Med J Aust. 2005 Nov 7;183(9):464-71. doi: 10.5694/j.1326-5377.2005.tb07124.x.
3
Efficacy of drug eluting stents in patients with and without diabetes mellitus: indirect comparison of controlled trials.药物洗脱支架在糖尿病患者与非糖尿病患者中的疗效:对照试验的间接比较
Heart. 2006 May;92(5):650-7. doi: 10.1136/hrt.2005.070698. Epub 2005 Oct 26.
4
Coronary artery stents: a rapid systematic review and economic evaluation.冠状动脉支架:一项快速系统评价与经济学评估
Health Technol Assess. 2004 Sep;8(35):iii-iv, 1-242. doi: 10.3310/hta8350.
5
Drug-eluting stents versus bare-metal stents for acute coronary syndrome.药物洗脱支架与裸金属支架治疗急性冠状动脉综合征的比较
Cochrane Database Syst Rev. 2017 Aug 23;8(8):CD012481. doi: 10.1002/14651858.CD012481.pub2.
6
Percutaneous coronary intervention with everolimus-eluting stents (Xience V): systematic review and direct-indirect comparison meta-analyses with paclitaxel-eluting stents (Taxus) and sirolimus-eluting stents (Cypher).依维莫司洗脱支架(Xience V)的经皮冠状动脉介入治疗:与紫杉醇洗脱支架(Taxus)和西罗莫司洗脱支架(Cypher)的系统评价及直接-间接比较的荟萃分析
Minerva Cardioangiol. 2008 Feb;56(1):55-65.
7
Drug-eluting stents: a systematic review and economic evaluation.药物洗脱支架:系统评价与经济学评估
Health Technol Assess. 2007 Nov;11(46):iii, xi-221. doi: 10.3310/hta11460.
8
Comparison of Drug-Eluting Stent with Bare-Metal Stent Implantation in Femoropopliteal Artery Disease: A Systematic Review and Meta-Analysis.药物洗脱支架与裸金属支架植入治疗股腘动脉疾病的比较:一项系统评价和荟萃分析。
Ann Vasc Surg. 2018 Jul;50:96-105. doi: 10.1016/j.avsg.2017.12.003. Epub 2018 Mar 4.
9
Next-generation drug-eluting stents in coronary artery disease: focus on everolimus-eluting stent (Xience V).冠状动脉疾病中的新一代药物洗脱支架:聚焦依维莫司洗脱支架(Xience V)。
Vasc Health Risk Manag. 2008;4(1):31-8. doi: 10.2147/vhrm.2008.04.01.31.
10
Impact of Target Lesion Revascularization on Long-Term Mortality After Percutaneous Coronary Intervention for Left Main Disease.左主干病变经皮冠状动脉介入治疗后靶病变血运重建对长期死亡率的影响。
JACC Cardiovasc Interv. 2024 Jan 8;17(1):32-42. doi: 10.1016/j.jcin.2023.10.068.

引用本文的文献

1
Primum non nocere. Quomo sapere?. Firstly, do no harm. How can we know this? Drug-eluting stents versus surgery.首要的是不伤害。我们如何知晓?药物洗脱支架与手术。 首先,不造成伤害。我们怎么知道这一点?药物洗脱支架与手术。
Sao Paulo Med J. 2008 May 1;126(3):143-4. doi: 10.1590/s1516-31802008000300001.

本文引用的文献

1
Inflammatory reaction after sirolimus-eluting stent implant.西罗莫司洗脱支架植入后的炎症反应。
Ann Thorac Surg. 2005 Nov;80(5):1903-4. doi: 10.1016/j.athoracsur.2004.05.079.
2
Inflammation and restenosis after percutaneous coronary interventions.经皮冠状动脉介入治疗后的炎症与再狭窄
Eur Heart J. 2004 Oct;25(19):1679-87. doi: 10.1016/j.ehj.2004.06.011.
3
Relation of an elevated white blood cell count after percutaneous coronary intervention to long-term mortality.经皮冠状动脉介入治疗后白细胞计数升高与长期死亡率的关系。
Am J Cardiol. 2004 Jul 15;94(2):190-2. doi: 10.1016/j.amjcard.2004.03.060.
4
Non-polymer-based paclitaxel-coated coronary stents for the treatment of patients with de novo coronary lesions: angiographic follow-up of the DELIVER clinical trial.用于治疗初发冠状动脉病变患者的非聚合物涂层紫杉醇冠状动脉支架:DELIVER临床试验的血管造影随访
Circulation. 2004 Apr 27;109(16):1948-54. doi: 10.1161/01.CIR.0000127129.94129.6F. Epub 2004 Apr 12.
5
The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS).加拿大西罗莫司洗脱支架治疗小的自身冠状动脉原发长病变患者的研究(C-SIRIUS)
J Am Coll Cardiol. 2004 Mar 17;43(6):1110-5. doi: 10.1016/j.jacc.2004.01.024.
6
Inhibition of restenosis with a paclitaxel-eluting, polymer-free coronary stent: the European evaLUation of pacliTaxel Eluting Stent (ELUTES) trial.使用不含聚合物的紫杉醇洗脱冠状动脉支架抑制再狭窄:欧洲紫杉醇洗脱支架(ELUTES)试验评估
Circulation. 2004 Feb 3;109(4):487-93. doi: 10.1161/01.CIR.0000109694.58299.A0. Epub 2004 Jan 26.
7
A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease.一种用于冠心病患者的基于聚合物的紫杉醇洗脱支架。
N Engl J Med. 2004 Jan 15;350(3):221-31. doi: 10.1056/NEJMoa032441.
8
Role of membrane potential and expression of endothelial factors in restenosis after angioplasty in SHR.
Hypertension. 2004 Jan;43(1):131-5. doi: 10.1161/01.HYP.0000105300.74809.4F. Epub 2003 Nov 24.
9
Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS).西罗莫司洗脱支架治疗小冠状动脉长动脉粥样硬化病变患者:双盲、随机对照试验(E-SIRIUS)
Lancet. 2003 Oct 4;362(9390):1093-9. doi: 10.1016/S0140-6736(03)14462-5.
10
Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery.雷帕霉素洗脱支架与标准支架治疗冠状动脉狭窄患者的比较
N Engl J Med. 2003 Oct 2;349(14):1315-23. doi: 10.1056/NEJMoa035071.